date:Apr 24, 2013
velopment are biologics, often delivered by injection, and are more complex, targeted and longer lasting in the body than the earlier failed attempts, Lenz said.
Amgens AMG 334 and Alders ALD 403 are being tested in the second of three clinical trials typically required for US regulatory approval.
Well have data on this before the year is out, Randall Schatzman, chief executive officer of closely held Alder, based in Bothell, Washington, said in an interview.